Plasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis

Marta Tejera-Alhambra; Armanda Casrouge; Clara de Andrés; Ansgar Seyfferth; Rocío Ramos-Medina; Bárbara Alonso; Janet Vega; Lidia Fernández-Paredes; Matthew L. Albert; Silvia Sánchez-Ramón

doi:10.1371/journal.pone.0128952

Loading metrics

Open Access

Peer-reviewed

Research Article

Plasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis

Marta Tejera-Alhambra,

Affiliation Department of Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
⨯
Armanda Casrouge,

Affiliations Department of Immunology, Center for Human Immunology, Institut Pasteur, Paris, France, Department of Immunology, INSERM U818, Institut Pasteur, Paris, France
⨯
Clara de Andrés,

Affiliation Department of Neurology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
⨯
Ansgar Seyfferth,

Affiliation STAT-UP Statistical Consulting&Services, Madrid, Spain
⨯
Rocío Ramos-Medina,

Current address: Department of Clinical Oncology, Laboratory of Translational Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Affiliation Department of Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
⨯
Bárbara Alonso,

Affiliation Department of Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
⨯
Janet Vega,

Affiliation Center Alicia Koplowitz for Multiple Sclerosis of the Community of Madrid, Madrid, Spain
⨯
Lidia Fernández-Paredes,

Affiliation Department of Clinical Immunology, Hospital Clínico San Carlos, Madrid, Spain
⨯
Matthew L. Albert,

Affiliations Department of Immunology, Center for Human Immunology, Institut Pasteur, Paris, France, Department of Immunology, INSERM U818, Institut Pasteur, Paris, France
⨯
Silvia Sánchez-Ramón

* E-mail: ssramon@salud.madrid.org

Current address: Department of Clinical Immunology, Hospital Clínico San Carlos, Madrid, Spain

Affiliation Department of Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
⨯

Plasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis

Marta Tejera-Alhambra,
Armanda Casrouge,
Clara de Andrés,
Ansgar Seyfferth,
Rocío Ramos-Medina,
Bárbara Alonso,
Janet Vega,
Lidia Fernández-Paredes,
Matthew L. Albert,
Silvia Sánchez-Ramón

Published: June 3, 2015
https://doi.org/10.1371/journal.pone.0128952

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Multiple sclerosis
Is the Subject Area "Multiple sclerosis" applicable to this article?

Thanks for your feedback.
Biomarkers
Is the Subject Area "Biomarkers" applicable to this article?

Thanks for your feedback.
Chemokines
Is the Subject Area "Chemokines" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Growth factors
Is the Subject Area "Growth factors" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Cerebrospinal fluid
Is the Subject Area "Cerebrospinal fluid" applicable to this article?

Thanks for your feedback.
Central nervous system
Is the Subject Area "Central nervous system" applicable to this article?

Thanks for your feedback.